ARTICLE | Company News
Apeiron Biologics, Evotec deal
November 1, 2010 7:00 AM UTC
Evotec will use its preclinical screening technologies and assay development to evaluate small molecule modulators of downstream regulatory element antagonistic modulator (DREAM) discovered by Apeiro...